Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Fox Chase Bancorp IncListing unverified | OtherD (derivative) | — | SEC | |
Fox Chase Bancorp IncListing unverified | Other | — | SEC | |
Fox Chase Bancorp IncListing unverified | Award | — | SEC | |
Fox Chase Bancorp IncListing unverified | Other | — | SEC | |
Fox Chase Bancorp IncListing unverified | OtherD (derivative) | — | SEC | |
Fox Chase Bancorp IncListing unverified | Award | — | SEC | |
Fox Chase Bancorp IncListing unverified | AwardD (derivative) | — | SEC | |
Fox Chase Bancorp IncListing unverified | Other | — | SEC | |
Fox Chase Bancorp IncListing unverified | OtherD (derivative) | — | SEC | |
Fox Chase Bancorp IncListing unverified | Buy | $50K | SEC | |
Fox Chase Bancorp IncListing unverified | Other | — | SEC | |
Fox Chase Bancorp IncListing unverified | Other | — | SEC | |
Fox Chase Bancorp IncListing unverified | Buy | $35.9K | SEC | |
Fox Chase Bancorp IncListing unverified | Award | — | SEC | |
Fox Chase Bancorp IncListing unverified | AwardD (derivative) | — | SEC | |
Celldex Therapeutics, Inc.Listing on record | AwardD (derivative) | $14.4K | SEC | |
Fox Chase Bancorp IncListing unverified | Buy | $27.8K | SEC | |
Fox Chase Bancorp IncListing unverified | Buy | $50.1K | SEC | |
Celldex Therapeutics, Inc.Listing on record | AwardD (derivative) | $17.6K | SEC | |
Celldex Therapeutics, Inc.Listing on record | AwardD (derivative) | $14.5K | SEC | |
Celldex Therapeutics, Inc.Listing on record | Buy | $20.4K | SEC | |
Celldex Therapeutics, Inc.Listing on record | AwardD (derivative) | $26.8K | SEC |